Stock Splits
By The Online Investor Staff, updated Tue., Nov. 19, 5:04 AM
| This Slide: #5 of 25 |
Slide #5. Cancer Genetics, Inc. (NASDAQ:CGIX) — 1 for 30 Reverse Split
Announced:
10/24/2019
Stock Split:
1 for 30
Record Date:
10/24/2019
Pay Date:
10/25/2019
CGIX Optionable?:
No
Cancer Genetics develops, commercializes and provides molecular- and biomarker-based tests and services, including proprietary preclinical oncology and immuno-oncology services, that enable biotech and pharmaceutical companies engaged in oncology and immuno-oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic and molecular factors influencing subject responses to therapeutics. Through Co.'s clinical services, Co. enables physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment. 
CGIX Detailed Information Page & Split History »
|
|||||||||||||||||||||
Open the CGIX Page at The Online Investor (in a new window) »
|
|
Avg. Broker Rec.
 
|
Hold (2.00 out of 4) 4th percentile
(ranked lower than approx. 96% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
